Use of antiepileptic or benzodiazepine medication and suicidal ideation - The Northern Finland Birth Cohort 1966

Epilepsy and Behavior

Volumn 46, Issue , 2015, Pages 198-204

  Rissanen, I ^a,b   Jaaskelainen E ^a,b   Isohanni, M ^a,c   Koponen, H ^c,d   Ansakorpi, H ^b,e   Miettunen, J ^a,b,c  

^a UNIVERSITY OF OULU   (Finland)

^b MEDICAL RESEARCH CENTER OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antiepileptic drugs; Anxiety; Benzodiazepines; Cohort study; Depression; Suicidal ideation

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE;

ADULT; ANXIETY DISORDER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FINLAND; HIGH RISK PATIENT; HOPKINS SYMPTOM CHECKLIST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; QUESTIONNAIRE; RISK ASSESSMENT; SUICIDAL IDEATION; EPILEPSY; PRESCRIPTION; STATISTICS AND NUMERICAL DATA;

ADULT; ANTICONVULSANTS; BENZODIAZEPINES; COHORT STUDIES; DRUG PRESCRIPTIONS; EPILEPSY; FEMALE; FINLAND; HUMANS; MALE; SUICIDAL IDEATION;

EID: 84946183327     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.03.001     Document Type: Article

References (36)

1. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog Neurobiol 2009, 89:315-333.
2. Bell G.S., Gaitatzis A., Bell C.L., Johnson A.L., Sander J.W. Suicide in people with epilepsy: how great is the risk?. Epilepsia 2009, 50:1933-1942.
3. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4(Suppl. 3):S31-S38.
4. Christensen J., Vestergaard M., Mortensen P.B., Sidenius P., Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007, 6:693-698.
5. Kessler R.C., Borges G., Walters E.E. Prevalence of and risk factors for lifetime suicide attempts in the national comorbidity survey. Arch Gen Psychiatry 1999, 56:617-626.
6. Kessler R.C., Berglund P., Borges G., Nock M., Wang P.S. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 2005, 293:2487-2495.
7. Nock M.K., Borges G., Bromet E.J., et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 2008, 192:98-105.
8. Tellez-Zenteno J.F., Patten S.B., Jette N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
9. Gaitatzis A., Carroll K., Majeed A.W., Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004, 45:1613-1622.
10. US Food and Drug Administration Antiepileptic drugs and suicidality Available at. http://Www.fda.gov/downloads/drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM192556.pdf.
11. Arana A., Wentworth C.E., Ayuso-Mateos J.L., Arellano F.M. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010, 363:542-551.
12. Mallon L., Broman J., Hetta J. Is usage of hypnotics associated with mortality?. Sleep Med 2009, 10:279-286.
13. Neutel C.I., Patten S.B. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997, 7:568-574.
14. Brower K.J., McCammon R.J., Wojnar M., Ilgen M.A., Wojnar J., Valenstein M. Prescription sleeping pills, insomnia, and suicidality in the national comorbidity survey replication. J Clin Psychiatry 2011, 72:515-521.
15. Jonas J.M., Hearron A.E. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. J Clin Psychopharmacol 1996, 16:208-211.
16. Wang P., Brookhart A., Ulbricht C., Schneeweiss S. The pharmacoepidemiology of psychiatric medications. Textbook in psychiatric epidemiology 2011, 155-165. Wiley-Blackwell. 3rd ed. M. Tsuang, M. Tohen, P. Jones (Eds.).
17. Haapea M., Miettunen J., Laara E., et al. Non-participation in a field survey with respect to psychiatric disorders. Scand J Public Health 2008, 36:728-736.
18. WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment 2011 2010, Norwegian Institute of Public Health, (Oslo).
19. Haapea M., Miettunen J., Lindeman S., Joukamaa M., Koponen H. Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 birth cohort. Int J Methods Psychiatr Res 2010, 19:88-96.
20. Veijola J., Jokelainen J., Laksy K., et al. The Hopkins Symptom Checklist - 25 in screening DSM-III-R axis-I disorders. Nord J Psychiatry 2003, 57:119-123.
21. Rissanen I., Jaaskeiainen E., Alaraisanen A., Isohanni M., Koponen H., Miettunen J. Use of antipsychotic medication and suicidality - the Northern Finland birth cohort 1966 study. Hum Psychopharmacol 2011, 26:e158-e159.
22. Norton P.J., Temple S.R., Pettit J.W. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression?. J Behav Ther Exp Psychiatry 2008, 39:515-525.
23. Suokas J.T., Perala J., Suominen K., Saarni S., Lonnqvist J., Suvisaari J.M. Epidemiology of suicide attempts among persons with psychotic disorder in the general population. Schizophr Res 2010, 124:22-28.
24. Diefenbach G.J., Woolley S.B., Goethe J.W. The association between self-reported anxiety symptoms and suicidality. J Nerv Ment Dis 2009, 197:92-97.
25. Lofgren E., Pouta A., von Wendt L., Tapanainen J., Isojarvi J.I., Jarvelin M.R. Epilepsy in the Northern Finland birth cohort 1966 with special reference to fertility. Epilepsy Behav 2009, 14:102-107.
26. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1989, 30:389-399.
27. Isohanni M., Makikyro T., Moring J., et al. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1997, 32:303-308.
28. Moilanen K., Veijola J., Laksy K., et al. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 birth cohort. Soc Psychiatry Psychiatr Epidemiol 2003, 38:305-310.
29. VanCott A.C., Cramer J.A., Copeland L.A., et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 2010, 8:4.
30. Gibbons R.D., Hur K., Brown C.H., Mann J.J. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009, 66:1354-1360.
31. Pugh M.J., Hesdorffer D., Wang C.P., et al. Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior. Neurology 2013, 81:1900-1906.
32. Voaklander D.C., Rowe B.H., Dryden D.M., Pahal J., Saar P., Kelly K.D. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health 2008, 62:138-146.
33. Nordfjaern T. A population-based cohort study of anxiety, depression, sleep and alcohol outcomes among benzodiazepine and z-hypnotic users. Addict Behav 2012, 37:1151-1157.
34. Tiihonen J., Suokas J.T., Suvisaari J.M., Haukka J., Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 2012, 69:476-483.
35. O'Carroll P.W., Berman A.L., Maris R.W., Moscicki E.K., Tanney B.L., Silverman M.M. Beyond the tower of Babel: a nomenclature for suicidology. Suicide Life Threat Behav 1996, 26:237-252.
36. Hecimovic H., Santos J.M., Carter J., et al. Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav 2012, 24:426-429.